Active Not RecruitingNCT05230537
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration
PHASE2 · 168 planned enrolment
- Countries listed
- 4
- Registry update
- September 22, 2026
immortal.lifePublic trial registrations naming Novartis Pharmaceuticals as an industry lead sponsor.
This is an independent registry-name view, not a verified corporate profile, portfolio valuation, ownership map, endorsement, or investment recommendation.
This does not mean that no transaction exists. A record appears only after its disclosure source and the connection to this exact registry sponsor identity are separately verified.
PHASE2 · 168 planned enrolment